Podcasts

Analyzing the Application of Precision Medicine in Austin

February 6th 2020

We traveled to Austin, Texas, for a State of the Science Summit™ on Precision Medicine, which featured insights from the Texas Oncology faculty.

Talking Tumors: Contemplating Clinical Conundrums in Lung Cancer

January 29th 2020

Lecia V. Sequist, MD, MPH, and Zofia Piotrowska, MD, MHS, give their input on how they approach cases that are often encountered in clinic.

Pondering Progress Made in GU Cancers in Phoenix

January 22nd 2020

We traveled to Phoenix, Arizona, for a State of the Science Summit™ on Genitourinary Cancers, which featured insights from the Mayo Clinic and Benner MD Anderson Cancer Center faculty.

Collaboration Saves Lives: Managing irAEs is a "Dynamic Discussion"

January 16th 2020

Omid Hamid, MD, and Grace Cherry, NP, share the importance of multidisciplinary care for patients with melanoma, how to best manage immunotherapy-related adverse events, and tips for developing trusting relationships with patients so that they feel comfortable reporting toxicities.

Airing Treatment Advances in Breast Cancer in New York

January 8th 2020

We traveled to Long Island, New York, for a State of the Science Summit™ on Breast Cancer, which featured insights from the NYU Langone’s Perlmutter Cancer Center faculty.

Stephanie Graff, MD: Information Is Power for Patients With Breast Cancer

January 1st 2020

Stephanie L. Graff, MD, shared the importance of personalizing care for her patients with breast cancer, how she balances her professional and personal life, using the optimal voice on social media, and her vision for the future of breast cancer treatment.

Outlining Advances Made in Ovarian Cancer in Oklahoma City

December 25th 2019

We traveled to Oklahoma City, Oklahoma, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from the Stephenson Cancer Center faculty.

Talking Tumors: Weill Cornell Medicine Experts Walk Through Challenging Breast Cancer Cases

December 18th 2019

Lisa Newman, MD, MPH, FACS, FASCO, and Alan B. Astrow, MD, discuss the need for systemic therapy in women with microinvasive triple-negative breast cancer and more intensive adjuvant therapy in women with intermediate-risk hormone receptor-positive, HER2-negative breast cancer.

Highlighting Progress Made in Hematologic Malignancies in Philly

December 11th 2019

We traveled to Philadelphia, Pennsylvania, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from the University of Pennsylvania faculty.

Checking Out Emerging Approaches in Lung Cancer Treatment in Chicago

December 4th 2019

We traveled to Chicago, Illinois, for a State of the Science Summit™ on Lung Cancer, which featured insights from the University of Chicago faculty.

Tanios Bekaii-Saab, MD: Not Just Seeing the Light, But Getting Out of the Tunnel

November 27th 2019

Dr. Tanios Bekaii-Saab spent time discussing the path to practicing in gastrointestinal malignancies, how he navigates balancing his professional and personal life, and mottos he has lived by throughout his career and while caring for his patients.

Reviewing Breakthroughs in Breast Cancer in Raleigh

November 20th 2019

We traveled to Raleigh, North Carolina, for a State of the Science Summit™ on Breast Cancer, which featured insights from the Duke Cancer Institute faculty.

Talking Tumors: Filling Data Gaps in Multiple Myeloma

November 14th 2019

We sat down with Ajai Chari, MD, and Sundar Jagannath, MD, both of Mount Sinai Hospital, to provide insight on controversial, but critical, questions regarding the merits of quadruplet versus triplet therapy in the newly diagnosed setting, the optimal maintenance approach in high-risk patients, and the data in support of and against initiating treatment in patients with smoldering multiple myeloma.

Spotlighting New Standards in Lung Cancer in Salt Lake City

November 7th 2019

We traveled to Salt Lake City, Utah, for a State of the Science Summit™ on Non–Small Cell Lung Cancer, which featured insights from the University of Utah and Intermountain Healthcare.

Howard "Skip" Burris, MD: A Passion for Befriending Patients and Always Being Kind

November 1st 2019

Howard A. Burris, MD, also known as "Skip," of Sarah Cannon Research Institute, discussed how he wound up in the oncology space, his passion for getting to know and helping his patients, and some proud moments throughout his monumental career.

Outlining Progress Made in Ovarian Cancer in Pittsburgh

October 24th 2019

We traveled to Pittsburgh, Pennsylvania, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from the University of Pittsburgh Medical Center faculty.

Talking Tumors: Adaptive Approaches in Triple-Negative and HR-Positive Breast Cancers

October 16th 2019

In keeping up with the expanding breast cancer treatment armamentarium, we sat down with Jane L. Meisel, MD, and Aditya Bardia, MD, MPH, who shed light on emerging treatment strategies for patients with metastatic triple-negative breast cancer and discussed the optimal timing of genomic testing in women with progressive hormone receptor–positive disease.

Spreading Newfound Treatment Strategies in Hematologic Malignancies in Seattle

October 9th 2019

We traveled to Seattle, Washington, for a State of the Science Summit™ on Hematologic Malignancies, which featured insights from Seattle Cancer Care Alliance faculty.

Examining Major Breakthroughs Made in Breast Cancer in Milwaukee

October 2nd 2019

We traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer, which featured insights from key thought leaders at Carbone Cancer Center of the University of Wisconsin.

Perusing Progress Made in Ovarian Cancer Treatment Paradigm in Pasadena

September 25th 2019

We traveled to Pasadena, California, for a State of the Science Summit™ on Ovarian Cancer, which featured insights from City of Hope faculty.